Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of HGMA-targeted phosphorothioate DNA aptamers to suppress carcinogenic activity and increase sensitivity to chemotherapy agents in human cancer cells

Use of HGMA-targeted phosphorothioate DNA aptamers to suppress carcinogenic activity and increase sensitivity to chemotherapy agents in human cancer cells

US Patent 9233119 · Granted Jan 12, 2016

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered oncolytic viruses containing hyper-binding sites to sequester and sup2020
Use of HMGA-targeted phosphorothioate DNA aptamers to suppress carcinogenic acti2016
Conveyor belt2009